AstraZeneca PLC (AZN)
AstraZeneca PLC
XNAS:AZN
92.48
$94.00 - 1.00
$92.00 - 600.00
$92.06
$92.77
$92.57
$93.32
94.02
61.24
3747957
5352382.3
3099698171.46
Chart
TendieTensor AI Analysis
Company
A merger between Astra of Sweden and Zeneca Group of the United Kingdom formed AstraZeneca in 1999. The firm sells branded drugs across a number of major therapeutic areas, including oncology (about 40% of total revenue), cardiovascular, renal, and metabolic (25%), rare disease (17%), and respiratory and immunology (15%). The majority of sales comes from international markets, with the United States representing close to one third of its sales.
Fundamentals
94,300
30.550247
6.264780
1.655522
100
BBG000BZ0DK8
BBG001SB80N8
3.10B
3.10B
Technicals
Short Interest
—
—
—
Higher = harder to cover
—
Prev: —
—
—
5D avg: —
—
Discussion
Login to participate in discussions.
Recent News
Related Stocks
Based on the portfolios of people who own AZN. This is a list generated by trading data from 3rd party trading platforms, and it's not a recommendation.